Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ARNOTT

Showing results (1041-1050 of 1,193) with videos related to

Pageof 120
Sort By:
American Heart Journal|July 1, 2022
Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension - the SaltSwitch Online Grocery Shopping randomized trialDamian Maganja, Kathy Trieu, Michelle Reading, et al.
Investigational New Drugs|July 14, 2016
A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemiaKaren W L Yee, Hsiao-Wei T Chen, David W Hedley, et al.
Neuroimage. Clinical|July 31, 2022
Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 reportJacqueline K Harris, Stefanie Hassel, Andrew D Davis, et al.
Gastroenterology|August 30, 2008
Definition of phenotypic characteristics of childhood-onset inflammatory bowel diseaseJohan Van Limbergen, Richard K Russell, Hazel E Drummond, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2022
Inflammatory bowel disease patient-reported quality assessment should drive service improvement: a national survey of UK IBD units and patientsA Barney Hawthorne, Jackie Glatter, Jonathan Blackwell, et al.
Diabetes, Obesity & Metabolism|May 19, 2022
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysisChao Li, Jie Yu, Carinna Hockham, et al.
Plos One|November 23, 2016
An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 InhibitionBrian Egan, Chih-Chi Yuan, Madeleine Lisa Craske, et al.
The Lancet. Diabetes & Endocrinology|June 24, 2026
Whole-population trends in obesity across dimensions of inequality in England, 2019-25: a retrospective, longitudinal cohort study of 54 million adultsRobert A Fletcher, Nathalie Conrad, Patrick Rockenschaub, et al.
Inflammatory Bowel Diseases|December 20, 2007
Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northern EuropeJ Van Limbergen, R K Russell, E R Nimmo, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 8, 2021
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney DiseaseSimke W Waijer, Taha Sen, Clare Arnott, et al.
Pageof 120

Showing results (1041-1050 of 1,193) with videos related to

Sort By:
Pageof 120
American Heart Journal|July 1, 2022
Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension - the SaltSwitch Online Grocery Shopping randomized trialDamian Maganja, Kathy Trieu, Michelle Reading, et al.
Investigational New Drugs|July 14, 2016
A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemiaKaren W L Yee, Hsiao-Wei T Chen, David W Hedley, et al.
Neuroimage. Clinical|July 31, 2022
Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 reportJacqueline K Harris, Stefanie Hassel, Andrew D Davis, et al.
Gastroenterology|August 30, 2008
Definition of phenotypic characteristics of childhood-onset inflammatory bowel diseaseJohan Van Limbergen, Richard K Russell, Hazel E Drummond, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2022
Inflammatory bowel disease patient-reported quality assessment should drive service improvement: a national survey of UK IBD units and patientsA Barney Hawthorne, Jackie Glatter, Jonathan Blackwell, et al.
Diabetes, Obesity & Metabolism|May 19, 2022
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysisChao Li, Jie Yu, Carinna Hockham, et al.
Plos One|November 23, 2016
An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 InhibitionBrian Egan, Chih-Chi Yuan, Madeleine Lisa Craske, et al.
The Lancet. Diabetes & Endocrinology|June 24, 2026
Whole-population trends in obesity across dimensions of inequality in England, 2019-25: a retrospective, longitudinal cohort study of 54 million adultsRobert A Fletcher, Nathalie Conrad, Patrick Rockenschaub, et al.
Inflammatory Bowel Diseases|December 20, 2007
Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northern EuropeJ Van Limbergen, R K Russell, E R Nimmo, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 8, 2021
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney DiseaseSimke W Waijer, Taha Sen, Clare Arnott, et al.
Pageof 120